Pricing Log in Create free account

908 Devices Inc. (MASS) vs NeuroPace, Inc. (NPCE)

908 Devices Inc. and NeuroPace, Inc. are both Medical Devices companies. 908 Devices Inc. and NeuroPace, Inc. are of similar size ($435.6M and $419.5M). 908 Devices Inc. grew revenue faster over the last twelve months: 13.4% against 11.6%. NeuroPace, Inc. has the higher net margin (−19.3% vs −57.0%) and the higher return on invested capital (−44.6% vs −96.4%). Across the 18 metrics below, NeuroPace, Inc. leads on 10 and 908 Devices Inc. on 8.

Valuation

Metric MASS NPCE Medical Devices median
P/E n/m n/m 25.58
P/S 6.34 4.35 2.54
P/B 3.04 36.22 2.48
Price to free cash flow 626.96 n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 4.92 4.47 2.72
Earnings yield (9.20%) (4.52%) (12.82%)
Free cash flow yield 0.16% (2.70%) (8.18%)

Profitability

Metric MASS NPCE Medical Devices median
Gross margin 52.16% 81.57% 57.76%
Operating margin (63.98%) (13.87%) (15.07%)
Net margin (56.96%) (19.34%) (14.45%)
Free cash flow margin 1.01% (11.75%) (3.88%)
Return on equity (25.15%) (122.05%) (10.35%)
Return on assets (17.81%) (18.82%) (17.26%)
Return on invested capital (96.41%) (44.64%) (5.27%)

Growth

Metric MASS NPCE Medical Devices median
Revenue growth (TTM) 13.35% 11.59% 10.41%
EPS growth (last fiscal year) 125.47% 29.03% 28.17%
Revenue growth, 5-year CAGR 15.88% 19.44% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MASS NPCE Medical Devices median
Debt to equity 0.00 4.97 0.04
Current ratio 2.67 4.94 2.74
Net debt to EBITDA 3.17 0.15 0.54

Dividend

Metric MASS NPCE Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric MASS NPCE Medical Devices median
Market cap 419.53m 435.58m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack